Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fabian

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cancer Immunology, Immunotherapy : CII|May 11, 2023
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian, et al.
Frontiers in Immunology|June 19, 2026
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer modelsJonelle K Lee, Kellsye P Fabian, Ginette S Santiago-Sanchez, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 27, 2013
[Malignant melanoma treated with radical chemotherapy, resemblance histology of melanoma to soft tissue sarcomas, case report]O Bílek, S Tuček, K Veselý, et al.
Applied Optics|October 22, 2010
Intercomparison of spectral-UV-radiation measurement systemsG Seckmeyer, S Thiel, M Blumthaler, et al.
Frontiers in Oncology|May 14, 2024
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrenceDiana C Lopez, Kellsye P Fabian, Michelle R Padget, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 31, 2013
[Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases]A Poprach, R Lakomý, I Selingerová, et al.
Elife|July 8, 2020
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cellsYvette Robbins, Sarah Greene, Jay Friedman, et al.
Environmental Pollution (Barking, Essex : 1987)|July 12, 2005
Comparison of ozone uptake and sensitivity between a phytotron study with young beech and a field experiment with adult beech (Fagus sylvatica)Angela J Nunn, A R Kozovits, I M Reiter, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009]M Svoboda, J Navrátil, P Fabian, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|May 11, 2023
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian, et al.
Frontiers in Immunology|June 19, 2026
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer modelsJonelle K Lee, Kellsye P Fabian, Ginette S Santiago-Sanchez, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 27, 2013
[Malignant melanoma treated with radical chemotherapy, resemblance histology of melanoma to soft tissue sarcomas, case report]O Bílek, S Tuček, K Veselý, et al.
Applied Optics|October 22, 2010
Intercomparison of spectral-UV-radiation measurement systemsG Seckmeyer, S Thiel, M Blumthaler, et al.
Frontiers in Oncology|May 14, 2024
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrenceDiana C Lopez, Kellsye P Fabian, Michelle R Padget, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 31, 2013
[Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases]A Poprach, R Lakomý, I Selingerová, et al.
Elife|July 8, 2020
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cellsYvette Robbins, Sarah Greene, Jay Friedman, et al.
Environmental Pollution (Barking, Essex : 1987)|July 12, 2005
Comparison of ozone uptake and sensitivity between a phytotron study with young beech and a field experiment with adult beech (Fagus sylvatica)Angela J Nunn, A R Kozovits, I M Reiter, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009]M Svoboda, J Navrátil, P Fabian, et al.
Pageof 10